VKH
ARMP icon

Virtu KCG Holdings’s Armata Pharmaceuticals ARMP Stock Holding History

Virtu KCG Holdings’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-94
Closed -$6K – 2858
2017
Q1 		$6K Sell
94
-1,803
-95% -$123K ﹤0.01% 3037
2016
Q4 		$117K Buy
1,897
+1,716
+948% +$213K ﹤0.01% 2853
2016
Q3 		$38K Buy
181
+73
+68% +$16.8K ﹤0.01% 2829
2016
Q2 		$23K Buy
+108
New +$37.3K ﹤0.01% 2781

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Virtu KCG Holdings's ARMP Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Armata Pharmaceuticals (ARMP) in Q2 2017, closing a stake of 94 shares — an estimated $6K sold.

Virtu KCG Holdings first reported a position in ARMP in Q2 2016 and held it in 4 quarters. The position peaked at $117K in Q4 2016. 11 funds tracked by Wall St. Rank hold ARMP as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Armata Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 94 Armata Pharmaceuticals shares in Q2 2017, an estimated $6K.
  • Virtu KCG Holdings first reported a position in Armata Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • Virtu KCG Holdings's Armata Pharmaceuticals position peaked at $117K in Q4 2016.
  • 11 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.